Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group. [electronic resource] by
- Rusthoven, J J
- Quirt, I C
- Iscoe, N A
- McCulloch, P B
- James, K W
- Lohmann, R C
- Jensen, J
- Burdette-Radoux, S
- Bodurtha, A J
- Silver, H K
- Verma, S
- Armitage, G R
- Zee, B
- Bennett, K
Producer: 19960822
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 14
Availability: No items available.
|